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Introduction
Alzheimer's disease (AD) is a devastating neurodegenerative disease that represents the most common form of dementia among the elderly population. Although the cause of AD has not been completely understood, accumulating evidence indicates that mitochondrial dysfunction and increased oxidative stress occur early in the progression of disease and thus may play an important role in the pathogenesis of AD (Galindo et al., 2010; Moreira et al., 2010; Reddy, 2009; Swerdlow and Khan, 2009) . Several in vitro studies have shown that exposure to amyloid-β (Aβ) peptides causes abnormalities of mitochondrial function as characterized by excessive mitochondrial membrane potential depolarization, uncoupling of the mitochondrial respiratory chain, reduced ATP, and increased reactive oxygen species (ROS) generation (Cardoso et al., 2004; Galindo et al., 2010; Reddy and Beal, 2008) . Interestingly, cells depleted of mitochondrial DNA are insensitive to Aβ, suggesting that Aβ-mediated neurotoxicity and apoptosis require functional mitochondria (Cardoso et al., 2001 (Cardoso et al., , 2002 . Moreover, Aβ overproduction induces abnormal mitochondrial dynamics through modulation of mitochondrial fission/fusion proteins (Wang et al., 2008) . Consistent with these findings, increased autophagocytosis of mitochondria is indeed a prominent feature of AD (Moreira et al., 2007; Swerdlow and Khan, 2009) .
Interestingly, recent investigations indicate that monomeric and oligomeric forms of Aβ are found in mitochondria of brains from AD patients and transgenic model mice, although the precise mechanism by which Aβ peptides are transported to mitochondrial membrane remains unclear (Caspersen et al., 2005; Dragicevic et al., 2010; Du et al., 2010; Hansson Petersen et al., 2008; Manczak et al., 2006) . Aβ is formed from amyloid precursor protein (APP) through its endoproteolysis by two enzymes. The β-secretase (called BACE1 for β-site APP-cleaving enzyme 1) cuts APP first to generate the N-terminus of Aβ, producing the intermittent β-cleaved C-terminal fragment (C99). The γ-secretase cleaves C99 subsequently to release Aβ peptides. Importantly, different lines of evidence show that not only Aβ peptides but also C99 fragments may contribute to the pathophysiology of AD such as neurodegeneration, endosome dysfunction, and Neurobiology of Disease 45 (2012) [417] [418] [419] [420] [421] [422] [423] [424] 
